|
|
|
Volumn 28, Issue 6, 1996, Pages 3110-3111
|
|
A single center experience with mycophenolate mofetil in the prevention of renal allograft rejection
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
THYMOCYTE ANTIBODY;
ADULT;
AGED;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG SCREENING;
FEMALE;
FOLLOW UP;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY ALLOGRAFT;
KIDNEY ALLOGRAFT REJECTION;
MALE;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
DOUBLE-BLIND METHOD;
EUROPE;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY TESTING;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MUROMONAB-CD3;
MYCOPHENOLIC ACID;
PLACEBOS;
POSTOPERATIVE COMPLICATIONS;
SURVIVAL RATE;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0029845562
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
